Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
– Expands patient access to opioid-sparing pain control and advances 5×30 strategy – BRISBANE, Calif., Oct. 05, 2026…
#Europe #EU #Agreement #and #Announces #Commercialize #European #EuropeanUnion #exclusive #EXPAREL® #Farmaceutici #in #kingdom #Molteni #Pacira #the #to #Union #united #with
https://www.europesays.com/europe/152509/